Adam Lenkowsky insider trades

Open-market stock purchases and sales by Adam Lenkowsky, EVP, Chief Commercial Officer at Bristol Myers Squibb Co, from SEC Form 4 filings since May 1, 2023.

Recent trades

DateStockTradeValue
May 1, 2026BMY Bristol Myers Squibb CoSold (not open market)—
May 1, 2026BMY Bristol Myers Squibb CoSold (not open market)$34.9K
May 1, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$50K
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$54.9K
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$188K
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$129K
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Nov 3, 2025BMY Bristol Myers Squibb CoBought (not open market)—

Companies traded

  • BMY Bristol Myers Squibb Co: other filings, last May 1, 2026

Get free alerts when Adam Lenkowsky files a new trade →